长春高新(000661.SZ)：子公司GenSci141软膏境内生产药品注册临床试验申请获得受理

Core Viewpoint - Changchun High-tech (000661.SZ) announced that its subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (referred to as "Jinsai Pharmaceutical"), has received the Acceptance Notice issued by the National Medical Products Administration for the clinical trial application of GenSci141 ointment, a dual dihydrotestosterone ointment developed by Jinsai Pharmaceutical [1] Group 1 - Jinsai Pharmaceutical's GenSci141 ointment is designed to act through paracrine mechanisms in target tissues [1] - The product falls under chemical drugs categories 2.2 and 2.4 [1]